Many Americans pay hundreds of dollars per month for brand-name semaglutide without insurance. With a manufacturer savings card, the cost can drop significantly for eligible commercially insured patients. Self-pay through a telehealth clinic using compounded semaglutide typically runs $200–$500 per month, though that route carries real regulatory caveats worth understanding before you commit.
Three common scenarios:
Your immediate next step: call the member services number on your insurance card and ask whether semaglutide is on your formulary and what tier. If it is not covered, a telehealth consult is the fastest path to a prescription and a cost estimate.
Brand-name semaglutide has a high cash price, but commercially insured patients using a manufacturer savings card can pay substantially less, making insurance status the single biggest driver of out-of-pocket cost.
| Point | Details |
|---|---|
| Cash price range | Brand-name semaglutide runs several hundred to over a thousand dollars per month without insurance or discounts. |
| Biggest savings lever | Commercially insured patients should check the Novo Nordisk savings card first; eligible patients may pay significantly reduced amounts per month. |
| Compounded semaglutide | Costs $200–$500 per month but carries FDA-documented quality and safety risks; use only 503B-registered pharmacies. |
| Insurance coverage gap | Diabetes indications (Ozempic, Rybelsus) are more likely covered than weight-loss indications (Wegovy); prior authorization is required for all three. |
| AM Rx option | AM Rx offers same-day telehealth consults, insurance handling, and transparent self-pay pricing for GLP-1 prescriptions. |
The sticker price varies significantly depending on which product you’re prescribed, the dose you’re on, and whether you’re using it for diabetes or weight loss. Here’s what the three main brand-name options look like at the pharmacy counter.
Dosing and formulation details are drawn from FDA product labeling for semaglutide and the alternate 2026 label file.
How dose escalation changes your monthly count. Wegovy follows a structured semaglutide dosing schedule: you start at 0.25 mg weekly for four weeks, then step up every four weeks (0.5 mg, 1 mg, 1.7 mg) until reaching the 2.4 mg maintenance dose. Each Wegovy box contains four pens, which is exactly one month’s supply at any single dose level. Ozempic pens come in multi-dose format: a single 1 mg/dose pen delivers four weekly injections, so one pen covers one month at that dose. Rybelsus is simpler: 30 tablets per box equals one month at any dose.
The escalation schedule matters for budgeting because your dose, and therefore your pen strength, changes every month for the first five months. Some pharmacies stock certain strengths inconsistently, which can create gaps. Confirming availability before your prescription is sent in saves a frustrating wait.
Paying cash at a retail pharmacy for brand-name semaglutide is expensive by any measure. Wegovy’s cash price runs several hundred dollars per month depending on the pharmacy and your dose. Ozempic and Rybelsus are in a comparable price range. Geography plays a role too: prices at independent pharmacies sometimes differ from large chains, and warehouse clubs like Costco Pharmacy often post lower cash prices than CVS or Walgreens.
Telehealth clinic packages change the math considerably. Most telehealth providers bundle the consult fee, prescription evaluation, and sometimes the medication itself into a monthly subscription. Compounded semaglutide through these platforms typically runs $200–$500 per month, which is why so many patients pursue that route. The tradeoff is real, though.
Compounded semaglutide: the pros and cons
Pro Tip: If you go the compounded route, verify that the pharmacy holds a 503B outsourcing facility registration with the FDA, not just a state pharmacy license. The 503B designation requires stricter quality controls.
The safest self-pay path is brand-name semaglutide through a licensed pharmacy with a GoodRx or manufacturer coupon applied. Compounded options from a verified 503B facility are a reasonable middle ground. Unverified online sources selling “semaglutide” without a prescription are a different category entirely and carry serious health risks.
The labeled indication on your prescription determines more about your out-of-pocket cost than almost anything else. Ozempic and Rybelsus are FDA-approved for type 2 diabetes, and most commercial insurance plans cover diabetes medications. Wegovy is approved for chronic weight management and cardiovascular risk reduction in adults with obesity, but weight-loss drugs face a much harder coverage path.
Prior authorization is standard for all three products. For Ozempic, insurers typically require documentation of a type 2 diabetes diagnosis, an A1C level, and evidence that metformin or another first-line agent was tried first. For Wegovy, the bar is higher: most plans require a BMI of 30 or above (or 27 with a weight-related comorbidity), documentation of a supervised diet program, and sometimes a specific cardiovascular risk profile. The VA’s formulary criteria for Wegovy illustrate how large payers structure these requirements, including step therapy and documentation standards that mirror what many commercial plans use.
Steps to check your coverage:
Medicare and Medicaid note. Medicare Part D plans are prohibited from covering drugs used solely for weight loss under current law, though coverage for Wegovy’s cardiovascular indication is an evolving area. Medicaid coverage varies by state. If you’re on Medicare or Medicaid, ask your plan specifically about the cardiovascular risk-reduction indication, which may open a different coverage pathway.
A standard prior authorization decision usually takes several business days. Appeals can take several weeks for a standard review, or a few days for an expedited appeal when medical necessity is documented.
The list price is not what most patients actually pay, and the gap between the two can be substantial. An HHS/ASPE analysis of prescription drug pricing explains why: rebates, manufacturer programs, and payer negotiations mean the sticker price at the pharmacy bears little relationship to net cost for many patients.
Savings checklist (check in this order):
Worked example: A commercially insured patient prescribed Wegovy at the 1 mg dose pays the retail cash price of roughly $1,100 per month without any discount. With the Novo Nordisk savings card, that drops to $25 per month for eligible patients. Without insurance but using GoodRx at a major chain, the price might fall to $850–$950 per month, still high but lower than the list price. The savings card is the single highest-impact move for commercially insured patients who have been denied coverage.
Federal price negotiations add another layer of context. CMS has selected additional drugs for Medicare price negotiations, and GLP-1 medications are under ongoing federal scrutiny. List prices and manufacturer offers may shift as those negotiations progress.
The drug price is only part of what you’ll actually spend. Getting semaglutide legally requires a prescription, and that prescription requires a clinical evaluation. Depending on where you get care, the associated fees can add $50–$300 or more to your first-month total.
Common fees to budget for:
Sample first-month total (self-pay, compounded semaglutide via telehealth): Consult fee ($99) + compounded semaglutide ($299) + labs ($100) + shipping ($15) = approximately $513 for month one, then roughly $314 per month ongoing.
Sample first-month total (commercially insured, brand-name Wegovy with savings card): Copay or savings card ($25) + telehealth or primary care visit ($30 copay) + labs (covered) = approximately $55 for month one if your plan covers the visit and labs.
The gap between these two scenarios is real, and it’s why checking your insurance formulary before booking a consult is worth the 10-minute phone call.
Getting a prescription is more straightforward than many patients expect, especially through telehealth. Here’s the practical sequence:
AM Rx is a telehealth platform built specifically for the kind of care that semaglutide patients need: fast access, transparent pricing, and ongoing clinical support without the friction of a traditional clinic. The GLP-1 prescription weight loss program at AM Rx covers the full cycle from initial evaluation to prescription fulfillment and follow-up.
What the service includes:
AM Rx offers both insurance and self-pay options. For patients with commercial insurance, the team handles prior authorization submission and formulary navigation. For self-pay patients, pricing is disclosed upfront before you commit. There are no surprise fees after the consult.
The platform operates under licensed medical oversight, with prescribers who follow FDA labeling guidelines and current clinical standards for GLP-1 therapy. All prescriptions are issued through licensed practitioners following a clinical evaluation, not an automated questionnaire.
For patients weighing semaglutide versus tirzepatide, AM Rx providers can discuss both options and help you understand the cost and clinical differences before deciding.
The cheapest option is not always the right one, and the most expensive option is not automatically the safest. That’s the honest framing most cost guides skip.
The patients who end up in the worst situations are usually the ones who found a $99/month “semaglutide” offer online, skipped the clinical evaluation, and received a product with no verifiable dosing accuracy. The FDA’s warnings about unapproved GLP-1 products are not bureaucratic noise. Mislabeled doses in compounded products have sent patients to emergency rooms.
What actually matters when choosing where to get semaglutide:
The coverage-first approach is the right default. Spend 10 minutes on the phone with your insurer before you spend $400 on a self-pay consult. If coverage is denied, then weigh your options. The semaglutide benefits and clinical evidence support long-term use for many patients, which means the monthly cost compounds over time. A $200 difference per month is $2,400 per year. Getting the coverage question right at the start is worth the effort.
Most patients spend more time confused about pricing than they do actually getting care. AM Rx cuts through that. You get a same-day or next-day virtual consult with a licensed provider, a clear cost breakdown before you commit, and a prescription sent directly to your pharmacy or your door.
For commercially insured patients, AM Rx handles prior authorization and formulary navigation so you’re not doing that alone. For self-pay patients, the pricing is disclosed upfront, with no hidden fees after the visit. Both routes are available through the same platform.
The AM Rx weight loss program covers GLP-1 prescribing, ongoing follow-up, and home delivery, all through licensed providers who follow current FDA labeling standards. If you’re ready to find out what semaglutide would actually cost for your specific situation, start your telehealth consult at AM Rx today.
The following primary sources were used to estimate prices, coverage patterns, and safety guidance throughout this guide:
This article provides general information only and is not a substitute for professional medical or financial advice. Confirm current coverage rules with your insurer and discuss treatment options with a licensed healthcare provider.
Rybelsus (oral semaglutide) carries a similar list price to Ozempic, roughly $900 per month at cash price, so it is not meaningfully cheaper than the injectable options. Coverage likelihood is comparable since both are labeled for type 2 diabetes.
Most patients regain a significant portion of lost weight after stopping semaglutide, as the drug’s appetite-suppressing effects are not permanent. Clinical data consistently shows that the benefits are tied to continued use, which is why long-term cost planning matters.
According to FDA product labeling, Ozempic pens are available in 0.5 mg, 1 mg, and 2 mg per dose strengths, with each pen delivering four weekly injections. One pen covers one month at a single maintenance dose.
The most practical routes are the Novo Nordisk savings card (for commercially insured patients), GoodRx for cash-price reductions at retail pharmacies, or compounded semaglutide through a licensed telehealth provider at $200–$500 per month. The AM Rx weight loss program offers transparent self-pay pricing and can help navigate insurance options as well.
